nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS1—kidney cancer	0.36	0.636	CbGaD
Meclofenamic acid—PTGS2—kidney cancer	0.206	0.364	CbGaD
Meclofenamic acid—AKR1C3—Doxorubicin—kidney cancer	0.168	1	CbGbCtD
Meclofenamic acid—AKR1C3—Vincristine—Vinblastine—kidney cancer	0.00228	0.554	CbGdCrCtD
Meclofenamic acid—PTGS2—nephron—kidney cancer	0.00183	0.145	CbGeAlD
Meclofenamic acid—AKR1C3—Vinblastine—Vincristine—kidney cancer	0.00183	0.446	CbGdCrCtD
Meclofenamic acid—KCNQ2—gonad—kidney cancer	0.00149	0.118	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—TP53—kidney cancer	0.0012	0.192	CrCbGaD
Meclofenamic acid—AKR1C3—nephron tubule—kidney cancer	0.00117	0.0923	CbGeAlD
Meclofenamic acid—SLC22A6—nephron tubule—kidney cancer	0.00117	0.092	CbGeAlD
Meclofenamic acid—SLCO1C1—renal system—kidney cancer	0.00116	0.0914	CbGeAlD
Meclofenamic acid—SLCO1C1—kidney—kidney cancer	0.00112	0.0883	CbGeAlD
Meclofenamic acid—AKR1C3—cortex of kidney—kidney cancer	0.001	0.079	CbGeAlD
Meclofenamic acid—SLC22A6—cortex of kidney—kidney cancer	0.000998	0.0787	CbGeAlD
Meclofenamic acid—AKR1C3—cardiac atrium—kidney cancer	0.000953	0.0752	CbGeAlD
Meclofenamic acid—Lumiracoxib—PTGS1—kidney cancer	0.000693	0.111	CrCbGaD
Meclofenamic acid—Salsalate—PTGS1—kidney cancer	0.000548	0.0878	CrCbGaD
Meclofenamic acid—Gastrointestinal pain—Pazopanib—kidney cancer	0.000457	0.00302	CcSEcCtD
Meclofenamic acid—Discomfort—Vinblastine—kidney cancer	0.000457	0.00301	CcSEcCtD
Meclofenamic acid—Renal failure—Gemcitabine—kidney cancer	0.000456	0.00301	CcSEcCtD
Meclofenamic acid—Discomfort—Everolimus—kidney cancer	0.000455	0.003	CcSEcCtD
Meclofenamic acid—Stomatitis—Gemcitabine—kidney cancer	0.000452	0.00298	CcSEcCtD
Meclofenamic acid—Abdominal pain—Pazopanib—kidney cancer	0.000442	0.00292	CcSEcCtD
Meclofenamic acid—Oedema—Everolimus—kidney cancer	0.000441	0.00291	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Capecitabine—kidney cancer	0.000438	0.00289	CcSEcCtD
Meclofenamic acid—Alopecia—Dactinomycin—kidney cancer	0.000434	0.00287	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Gemcitabine—kidney cancer	0.000433	0.00286	CcSEcCtD
Meclofenamic acid—Oedema—Erlotinib—kidney cancer	0.000426	0.00281	CcSEcCtD
Meclofenamic acid—Asthenia—Temsirolimus—kidney cancer	0.000426	0.00281	CcSEcCtD
Meclofenamic acid—Anorexia—Vinblastine—kidney cancer	0.000422	0.00279	CcSEcCtD
Meclofenamic acid—Anorexia—Everolimus—kidney cancer	0.000421	0.00278	CcSEcCtD
Meclofenamic acid—Leukopenia—Sorafenib—kidney cancer	0.00042	0.00277	CcSEcCtD
Meclofenamic acid—Pruritus—Temsirolimus—kidney cancer	0.00042	0.00277	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS1—kidney cancer	0.00042	0.0673	CrCbGaD
Meclofenamic acid—Haemoglobin—Gemcitabine—kidney cancer	0.000418	0.00276	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Doxorubicin—kidney cancer	0.000418	0.00276	CcSEcCtD
Meclofenamic acid—Haemorrhage—Gemcitabine—kidney cancer	0.000416	0.00275	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS1—kidney cancer	0.000409	0.0656	CrCbGaD
Meclofenamic acid—Neutropenia—Paclitaxel—kidney cancer	0.000407	0.00269	CcSEcCtD
Meclofenamic acid—Diarrhoea—Temsirolimus—kidney cancer	0.000406	0.00268	CcSEcCtD
Meclofenamic acid—Anorexia—Erlotinib—kidney cancer	0.000406	0.00268	CcSEcCtD
Meclofenamic acid—Leukopenia—Sunitinib—kidney cancer	0.000404	0.00267	CcSEcCtD
Meclofenamic acid—Asthenia—Pazopanib—kidney cancer	0.000401	0.00265	CcSEcCtD
Meclofenamic acid—Insomnia—Everolimus—kidney cancer	0.000399	0.00263	CcSEcCtD
Meclofenamic acid—Paraesthesia—Vinblastine—kidney cancer	0.000398	0.00263	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Dactinomycin—kidney cancer	0.000397	0.00262	CcSEcCtD
Meclofenamic acid—Paraesthesia—Everolimus—kidney cancer	0.000396	0.00262	CcSEcCtD
Meclofenamic acid—Lumiracoxib—PTGS2—kidney cancer	0.000396	0.0635	CrCbGaD
Meclofenamic acid—Nocturia—Doxorubicin—kidney cancer	0.000396	0.00261	CcSEcCtD
Meclofenamic acid—Pruritus—Pazopanib—kidney cancer	0.000395	0.00261	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Gemcitabine—kidney cancer	0.000394	0.0026	CcSEcCtD
Meclofenamic acid—Ulcer—Doxorubicin—kidney cancer	0.000388	0.00256	CcSEcCtD
Meclofenamic acid—Alopecia—Vincristine—kidney cancer	0.000388	0.00256	CcSEcCtD
Meclofenamic acid—Malaise—Dactinomycin—kidney cancer	0.000386	0.00255	CcSEcCtD
Meclofenamic acid—Insomnia—Erlotinib—kidney cancer	0.000385	0.00254	CcSEcCtD
Meclofenamic acid—Decreased appetite—Vinblastine—kidney cancer	0.000385	0.00254	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000385	0.00254	CcSEcCtD
Meclofenamic acid—Decreased appetite—Everolimus—kidney cancer	0.000384	0.00253	CcSEcCtD
Meclofenamic acid—Leukopenia—Dactinomycin—kidney cancer	0.000383	0.00253	CcSEcCtD
Meclofenamic acid—Diarrhoea—Pazopanib—kidney cancer	0.000382	0.00252	CcSEcCtD
Meclofenamic acid—Renal failure—Paclitaxel—kidney cancer	0.000382	0.00252	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Everolimus—kidney cancer	0.000381	0.00252	CcSEcCtD
Meclofenamic acid—Fatigue—Everolimus—kidney cancer	0.00038	0.00251	CcSEcCtD
Meclofenamic acid—Constipation—Vinblastine—kidney cancer	0.000379	0.0025	CcSEcCtD
Meclofenamic acid—Stomatitis—Paclitaxel—kidney cancer	0.000378	0.0025	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Paclitaxel—kidney cancer	0.000377	0.00249	CcSEcCtD
Meclofenamic acid—Constipation—Everolimus—kidney cancer	0.000377	0.00249	CcSEcCtD
Meclofenamic acid—Vomiting—Temsirolimus—kidney cancer	0.000377	0.00249	CcSEcCtD
Meclofenamic acid—PTGS1—renal system—kidney cancer	0.000376	0.0297	CbGeAlD
Meclofenamic acid—Decreased appetite—Erlotinib—kidney cancer	0.00037	0.00244	CcSEcCtD
Meclofenamic acid—Oedema—Sunitinib—kidney cancer	0.000369	0.00243	CcSEcCtD
Meclofenamic acid—Alopecia—Gemcitabine—kidney cancer	0.000368	0.00243	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000368	0.00243	CcSEcCtD
Meclofenamic acid—Fatigue—Erlotinib—kidney cancer	0.000367	0.00242	CcSEcCtD
Meclofenamic acid—Anorexia—Sorafenib—kidney cancer	0.000365	0.00241	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Vinblastine—kidney cancer	0.000365	0.00241	CcSEcCtD
Meclofenamic acid—Constipation—Erlotinib—kidney cancer	0.000364	0.0024	CcSEcCtD
Meclofenamic acid—PTGS1—kidney—kidney cancer	0.000364	0.0287	CbGeAlD
Meclofenamic acid—Feeling abnormal—Everolimus—kidney cancer	0.000364	0.0024	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Vinblastine—kidney cancer	0.000362	0.00239	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Everolimus—kidney cancer	0.000361	0.00238	CcSEcCtD
Meclofenamic acid—PTGS2—renal system—kidney cancer	0.00036	0.0284	CbGeAlD
Meclofenamic acid—Discomfort—Dactinomycin—kidney cancer	0.00036	0.00237	CcSEcCtD
Meclofenamic acid—Vomiting—Pazopanib—kidney cancer	0.000355	0.00235	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—kidney cancer	0.000353	0.00233	CcSEcCtD
Meclofenamic acid—Nausea—Temsirolimus—kidney cancer	0.000352	0.00233	CcSEcCtD
Meclofenamic acid—Anorexia—Sunitinib—kidney cancer	0.000351	0.00232	CcSEcCtD
Meclofenamic acid—Haemoglobin—Paclitaxel—kidney cancer	0.00035	0.00231	CcSEcCtD
Meclofenamic acid—Abdominal pain—Vinblastine—kidney cancer	0.00035	0.00231	CcSEcCtD
Meclofenamic acid—Oedema—Dactinomycin—kidney cancer	0.000349	0.0023	CcSEcCtD
Meclofenamic acid—Abdominal pain—Everolimus—kidney cancer	0.000349	0.0023	CcSEcCtD
Meclofenamic acid—Haemorrhage—Paclitaxel—kidney cancer	0.000349	0.0023	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Erlotinib—kidney cancer	0.000348	0.0023	CcSEcCtD
Meclofenamic acid—PTGS2—kidney—kidney cancer	0.000348	0.0274	CbGeAlD
Meclofenamic acid—Leukopenia—Vincristine—kidney cancer	0.000342	0.00226	CcSEcCtD
Meclofenamic acid—PTGS1—cardiac atrium—kidney cancer	0.000337	0.0266	CbGeAlD
Meclofenamic acid—Salicylic acid—PTGS1—kidney cancer	0.000337	0.054	CrCbGaD
Meclofenamic acid—Abdominal pain—Erlotinib—kidney cancer	0.000337	0.00222	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Gemcitabine—kidney cancer	0.000336	0.00222	CcSEcCtD
Meclofenamic acid—Neutropenia—Capecitabine—kidney cancer	0.000334	0.00221	CcSEcCtD
Meclofenamic acid—Insomnia—Sunitinib—kidney cancer	0.000333	0.0022	CcSEcCtD
Meclofenamic acid—Decreased appetite—Sorafenib—kidney cancer	0.000333	0.0022	CcSEcCtD
Meclofenamic acid—Anorexia—Dactinomycin—kidney cancer	0.000333	0.0022	CcSEcCtD
Meclofenamic acid—Nausea—Pazopanib—kidney cancer	0.000332	0.00219	CcSEcCtD
Meclofenamic acid—Paraesthesia—Sunitinib—kidney cancer	0.000331	0.00218	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000331	0.00218	CcSEcCtD
Meclofenamic acid—Fatigue—Sorafenib—kidney cancer	0.00033	0.00218	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Paclitaxel—kidney cancer	0.00033	0.00218	CcSEcCtD
Meclofenamic acid—Constipation—Sorafenib—kidney cancer	0.000328	0.00216	CcSEcCtD
Meclofenamic acid—Malaise—Gemcitabine—kidney cancer	0.000327	0.00216	CcSEcCtD
Meclofenamic acid—Tinnitus—Paclitaxel—kidney cancer	0.000325	0.00215	CcSEcCtD
Meclofenamic acid—Leukopenia—Gemcitabine—kidney cancer	0.000324	0.00214	CcSEcCtD
Meclofenamic acid—Decreased appetite—Sunitinib—kidney cancer	0.00032	0.00212	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000318	0.0021	CcSEcCtD
Meclofenamic acid—Asthenia—Vinblastine—kidney cancer	0.000318	0.0021	CcSEcCtD
Meclofenamic acid—Fatigue—Sunitinib—kidney cancer	0.000318	0.0021	CcSEcCtD
Meclofenamic acid—Asthenia—Everolimus—kidney cancer	0.000317	0.00209	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000316	0.00209	CcSEcCtD
Meclofenamic acid—Constipation—Sunitinib—kidney cancer	0.000315	0.00208	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Sorafenib—kidney cancer	0.000313	0.00207	CcSEcCtD
Meclofenamic acid—Renal failure—Capecitabine—kidney cancer	0.000313	0.00207	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—kidney cancer	0.000313	0.0502	CrCbGaD
Meclofenamic acid—Pruritus—Everolimus—kidney cancer	0.000312	0.00206	CcSEcCtD
Meclofenamic acid—Oedema—Vincristine—kidney cancer	0.000312	0.00206	CcSEcCtD
Meclofenamic acid—Stomatitis—Capecitabine—kidney cancer	0.000311	0.00205	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Capecitabine—kidney cancer	0.00031	0.00204	CcSEcCtD
Meclofenamic acid—Alopecia—Paclitaxel—kidney cancer	0.000308	0.00203	CcSEcCtD
Meclofenamic acid—Asthenia—Erlotinib—kidney cancer	0.000306	0.00202	CcSEcCtD
Meclofenamic acid—Discomfort—Gemcitabine—kidney cancer	0.000305	0.00201	CcSEcCtD
Meclofenamic acid—Urticaria—Sorafenib—kidney cancer	0.000304	0.00201	CcSEcCtD
Meclofenamic acid—Decreased appetite—Dactinomycin—kidney cancer	0.000303	0.002	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vinblastine—kidney cancer	0.000303	0.002	CcSEcCtD
Meclofenamic acid—Abdominal pain—Sorafenib—kidney cancer	0.000303	0.002	CcSEcCtD
Meclofenamic acid—Diarrhoea—Everolimus—kidney cancer	0.000302	0.00199	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS1—kidney cancer	0.000302	0.0484	CrCbGaD
Meclofenamic acid—Gastrointestinal pain—Sunitinib—kidney cancer	0.000301	0.00199	CcSEcCtD
Meclofenamic acid—Pruritus—Erlotinib—kidney cancer	0.000301	0.00199	CcSEcCtD
Meclofenamic acid—Fatigue—Dactinomycin—kidney cancer	0.000301	0.00199	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Capecitabine—kidney cancer	0.000297	0.00196	CcSEcCtD
Meclofenamic acid—Anorexia—Vincristine—kidney cancer	0.000297	0.00196	CcSEcCtD
Meclofenamic acid—Oedema—Gemcitabine—kidney cancer	0.000296	0.00195	CcSEcCtD
Meclofenamic acid—Abdominal pain—Sunitinib—kidney cancer	0.000291	0.00192	CcSEcCtD
Meclofenamic acid—Diarrhoea—Erlotinib—kidney cancer	0.000291	0.00192	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Dactinomycin—kidney cancer	0.000288	0.0019	CcSEcCtD
Meclofenamic acid—Haemoglobin—Capecitabine—kidney cancer	0.000287	0.0019	CcSEcCtD
Meclofenamic acid—Haemorrhage—Capecitabine—kidney cancer	0.000286	0.00189	CcSEcCtD
Meclofenamic acid—Vision blurred—Paclitaxel—kidney cancer	0.000286	0.00189	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000285	0.00188	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000282	0.00186	CcSEcCtD
Meclofenamic acid—Insomnia—Vincristine—kidney cancer	0.000282	0.00186	CcSEcCtD
Meclofenamic acid—Anorexia—Gemcitabine—kidney cancer	0.000282	0.00186	CcSEcCtD
Meclofenamic acid—Vomiting—Vinblastine—kidney cancer	0.000282	0.00186	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Paclitaxel—kidney cancer	0.000282	0.00186	CcSEcCtD
Meclofenamic acid—Vomiting—Everolimus—kidney cancer	0.000281	0.00185	CcSEcCtD
Meclofenamic acid—Paraesthesia—Vincristine—kidney cancer	0.00028	0.00185	CcSEcCtD
Meclofenamic acid—Abdominal pain—Dactinomycin—kidney cancer	0.000276	0.00182	CcSEcCtD
Meclofenamic acid—Diclofenac—CYP1A1—kidney cancer	0.000276	0.0442	CrCbGaD
Meclofenamic acid—Asthenia—Sorafenib—kidney cancer	0.000275	0.00181	CcSEcCtD
Meclofenamic acid—Malaise—Paclitaxel—kidney cancer	0.000274	0.00181	CcSEcCtD
Meclofenamic acid—Leukopenia—Paclitaxel—kidney cancer	0.000272	0.00179	CcSEcCtD
Meclofenamic acid—Decreased appetite—Vincristine—kidney cancer	0.000271	0.00179	CcSEcCtD
Meclofenamic acid—Pruritus—Sorafenib—kidney cancer	0.000271	0.00179	CcSEcCtD
Meclofenamic acid—Vomiting—Erlotinib—kidney cancer	0.000271	0.00179	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Capecitabine—kidney cancer	0.00027	0.00179	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Vincristine—kidney cancer	0.000269	0.00178	CcSEcCtD
Meclofenamic acid—Fatigue—Vincristine—kidney cancer	0.000269	0.00177	CcSEcCtD
Meclofenamic acid—Palpitations—Paclitaxel—kidney cancer	0.000268	0.00177	CcSEcCtD
Meclofenamic acid—Insomnia—Gemcitabine—kidney cancer	0.000268	0.00177	CcSEcCtD
Meclofenamic acid—Tinnitus—Capecitabine—kidney cancer	0.000267	0.00176	CcSEcCtD
Meclofenamic acid—Constipation—Vincristine—kidney cancer	0.000267	0.00176	CcSEcCtD
Meclofenamic acid—Paraesthesia—Gemcitabine—kidney cancer	0.000266	0.00175	CcSEcCtD
Meclofenamic acid—Asthenia—Sunitinib—kidney cancer	0.000264	0.00175	CcSEcCtD
Meclofenamic acid—Nausea—Vinblastine—kidney cancer	0.000263	0.00174	CcSEcCtD
Meclofenamic acid—Nausea—Everolimus—kidney cancer	0.000262	0.00173	CcSEcCtD
Meclofenamic acid—Diarrhoea—Sorafenib—kidney cancer	0.000262	0.00173	CcSEcCtD
Meclofenamic acid—Pruritus—Sunitinib—kidney cancer	0.000261	0.00172	CcSEcCtD
Meclofenamic acid—Decreased appetite—Gemcitabine—kidney cancer	0.000257	0.0017	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000255	0.00169	CcSEcCtD
Meclofenamic acid—Discomfort—Paclitaxel—kidney cancer	0.000255	0.00168	CcSEcCtD
Meclofenamic acid—Fatigue—Gemcitabine—kidney cancer	0.000255	0.00168	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Vincristine—kidney cancer	0.000255	0.00168	CcSEcCtD
Meclofenamic acid—Constipation—Gemcitabine—kidney cancer	0.000253	0.00167	CcSEcCtD
Meclofenamic acid—Nausea—Erlotinib—kidney cancer	0.000253	0.00167	CcSEcCtD
Meclofenamic acid—Alopecia—Capecitabine—kidney cancer	0.000253	0.00167	CcSEcCtD
Meclofenamic acid—Diarrhoea—Sunitinib—kidney cancer	0.000252	0.00166	CcSEcCtD
Meclofenamic acid—Asthenia—Dactinomycin—kidney cancer	0.00025	0.00165	CcSEcCtD
Meclofenamic acid—Oedema—Paclitaxel—kidney cancer	0.000248	0.00163	CcSEcCtD
Meclofenamic acid—Abdominal pain—Vincristine—kidney cancer	0.000246	0.00163	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Gemcitabine—kidney cancer	0.000244	0.00161	CcSEcCtD
Meclofenamic acid—Vomiting—Sorafenib—kidney cancer	0.000244	0.00161	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—kidney cancer	0.00024	0.0385	CrCbGaD
Meclofenamic acid—Diarrhoea—Dactinomycin—kidney cancer	0.000239	0.00158	CcSEcCtD
Meclofenamic acid—Anorexia—Paclitaxel—kidney cancer	0.000236	0.00156	CcSEcCtD
Meclofenamic acid—Vision blurred—Capecitabine—kidney cancer	0.000235	0.00155	CcSEcCtD
Meclofenamic acid—Vomiting—Sunitinib—kidney cancer	0.000234	0.00155	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—kidney cancer	0.000234	0.0375	CrCbGaD
Meclofenamic acid—Ill-defined disorder—Capecitabine—kidney cancer	0.000231	0.00153	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—kidney cancer	0.000228	0.00151	CcSEcCtD
Meclofenamic acid—Nausea—Sorafenib—kidney cancer	0.000228	0.0015	CcSEcCtD
Meclofenamic acid—Malaise—Capecitabine—kidney cancer	0.000225	0.00148	CcSEcCtD
Meclofenamic acid—Insomnia—Paclitaxel—kidney cancer	0.000224	0.00148	CcSEcCtD
Meclofenamic acid—Asthenia—Vincristine—kidney cancer	0.000224	0.00148	CcSEcCtD
Meclofenamic acid—Leukopenia—Capecitabine—kidney cancer	0.000223	0.00147	CcSEcCtD
Meclofenamic acid—Paraesthesia—Paclitaxel—kidney cancer	0.000222	0.00147	CcSEcCtD
Meclofenamic acid—Vomiting—Dactinomycin—kidney cancer	0.000222	0.00146	CcSEcCtD
Meclofenamic acid—Palpitations—Capecitabine—kidney cancer	0.00022	0.00145	CcSEcCtD
Meclofenamic acid—Nausea—Sunitinib—kidney cancer	0.000219	0.00145	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—kidney cancer	0.000215	0.00142	CcSEcCtD
Meclofenamic acid—Decreased appetite—Paclitaxel—kidney cancer	0.000215	0.00142	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000214	0.00141	CcSEcCtD
Meclofenamic acid—Fatigue—Paclitaxel—kidney cancer	0.000214	0.00141	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vincristine—kidney cancer	0.000213	0.00141	CcSEcCtD
Meclofenamic acid—Asthenia—Gemcitabine—kidney cancer	0.000212	0.0014	CcSEcCtD
Meclofenamic acid—Constipation—Paclitaxel—kidney cancer	0.000212	0.0014	CcSEcCtD
Meclofenamic acid—Discomfort—Capecitabine—kidney cancer	0.000209	0.00138	CcSEcCtD
Meclofenamic acid—Pruritus—Gemcitabine—kidney cancer	0.000209	0.00138	CcSEcCtD
Meclofenamic acid—Nausea—Dactinomycin—kidney cancer	0.000207	0.00137	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Paclitaxel—kidney cancer	0.000204	0.00135	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000204	0.00134	CcSEcCtD
Meclofenamic acid—Oedema—Capecitabine—kidney cancer	0.000203	0.00134	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000202	0.00134	CcSEcCtD
Meclofenamic acid—Diarrhoea—Gemcitabine—kidney cancer	0.000202	0.00134	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—kidney cancer	0.000202	0.00133	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—kidney cancer	0.0002	0.00132	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—kidney cancer	0.0002	0.00132	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—ABCB1—kidney cancer	0.000199	0.0319	CrCbGaD
Meclofenamic acid—Vomiting—Vincristine—kidney cancer	0.000198	0.00131	CcSEcCtD
Meclofenamic acid—Urticaria—Paclitaxel—kidney cancer	0.000197	0.0013	CcSEcCtD
Meclofenamic acid—Abdominal pain—Paclitaxel—kidney cancer	0.000196	0.00129	CcSEcCtD
Meclofenamic acid—Anorexia—Capecitabine—kidney cancer	0.000194	0.00128	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS2—kidney cancer	0.000193	0.0309	CrCbGaD
Meclofenamic acid—Agranulocytosis—Doxorubicin—kidney cancer	0.000192	0.00127	CcSEcCtD
Meclofenamic acid—Vomiting—Gemcitabine—kidney cancer	0.000188	0.00124	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—kidney cancer	0.000185	0.00122	CcSEcCtD
Meclofenamic acid—Nausea—Vincristine—kidney cancer	0.000185	0.00122	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—kidney cancer	0.000184	0.00122	CcSEcCtD
Meclofenamic acid—Insomnia—Capecitabine—kidney cancer	0.000184	0.00121	CcSEcCtD
Meclofenamic acid—Paraesthesia—Capecitabine—kidney cancer	0.000182	0.0012	CcSEcCtD
Meclofenamic acid—Asthenia—Paclitaxel—kidney cancer	0.000178	0.00117	CcSEcCtD
Meclofenamic acid—Decreased appetite—Capecitabine—kidney cancer	0.000177	0.00117	CcSEcCtD
Meclofenamic acid—Nausea—Gemcitabine—kidney cancer	0.000176	0.00116	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000175	0.00116	CcSEcCtD
Meclofenamic acid—Fatigue—Capecitabine—kidney cancer	0.000175	0.00116	CcSEcCtD
Meclofenamic acid—Pruritus—Paclitaxel—kidney cancer	0.000175	0.00116	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—kidney cancer	0.000174	0.00115	CcSEcCtD
Meclofenamic acid—Constipation—Capecitabine—kidney cancer	0.000174	0.00115	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS2—kidney cancer	0.000172	0.0276	CrCbGaD
Meclofenamic acid—Tinnitus—Doxorubicin—kidney cancer	0.000172	0.00113	CcSEcCtD
Meclofenamic acid—Diarrhoea—Paclitaxel—kidney cancer	0.000169	0.00112	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Capecitabine—kidney cancer	0.000167	0.00111	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.000166	0.0011	CcSEcCtD
Meclofenamic acid—Salicylic acid—ABCB1—kidney cancer	0.000164	0.0263	CrCbGaD
Meclofenamic acid—Alopecia—Doxorubicin—kidney cancer	0.000163	0.00108	CcSEcCtD
Meclofenamic acid—Urticaria—Capecitabine—kidney cancer	0.000161	0.00107	CcSEcCtD
Meclofenamic acid—Abdominal pain—Capecitabine—kidney cancer	0.000161	0.00106	CcSEcCtD
Meclofenamic acid—Vomiting—Paclitaxel—kidney cancer	0.000157	0.00104	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—kidney cancer	0.000151	0.000999	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—kidney cancer	0.000149	0.000983	CcSEcCtD
Meclofenamic acid—Nausea—Paclitaxel—kidney cancer	0.000147	0.000971	CcSEcCtD
Meclofenamic acid—Diclofenac—ABCB1—kidney cancer	0.000147	0.0235	CrCbGaD
Meclofenamic acid—Asthenia—Capecitabine—kidney cancer	0.000146	0.000962	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—kidney cancer	0.000145	0.000955	CcSEcCtD
Meclofenamic acid—Pruritus—Capecitabine—kidney cancer	0.000144	0.000949	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—kidney cancer	0.000144	0.000948	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—kidney cancer	0.000142	0.000936	CcSEcCtD
Meclofenamic acid—Diarrhoea—Capecitabine—kidney cancer	0.000139	0.000918	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—kidney cancer	0.000135	0.000891	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—kidney cancer	0.000131	0.000865	CcSEcCtD
Meclofenamic acid—Vomiting—Capecitabine—kidney cancer	0.000129	0.000853	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—kidney cancer	0.000125	0.000824	CcSEcCtD
Meclofenamic acid—Nausea—Capecitabine—kidney cancer	0.000121	0.000797	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—kidney cancer	0.000118	0.000782	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—kidney cancer	0.000118	0.000776	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—kidney cancer	0.000114	0.000752	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000113	0.000747	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—kidney cancer	0.000113	0.000746	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—kidney cancer	0.000112	0.000739	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—kidney cancer	0.000108	0.000713	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000107	0.000707	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—kidney cancer	0.000104	0.000687	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—kidney cancer	0.000104	0.000684	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—kidney cancer	9.4e-05	0.00062	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—kidney cancer	9.27e-05	0.000612	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—kidney cancer	8.96e-05	0.000592	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—kidney cancer	8.33e-05	0.00055	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—kidney cancer	7.78e-05	0.000514	CcSEcCtD
Meclofenamic acid—AKR1C3—Signaling Pathways—AKAP13—kidney cancer	5.31e-05	0.000579	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ACY1—kidney cancer	5.29e-05	0.000576	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—VEGFA—kidney cancer	5.05e-05	0.000551	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—VEGFA—kidney cancer	5.05e-05	0.000551	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CCBL1—kidney cancer	5.05e-05	0.00055	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.02e-05	0.000547	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5e-05	0.000545	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.98e-05	0.000543	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTT1—kidney cancer	4.94e-05	0.000539	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ACHE—kidney cancer	4.94e-05	0.000539	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTT1—kidney cancer	4.93e-05	0.000537	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ACHE—kidney cancer	4.93e-05	0.000537	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SLC2A1—kidney cancer	4.89e-05	0.000533	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.87e-05	0.000531	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GRB7—kidney cancer	4.86e-05	0.00053	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—JUNB—kidney cancer	4.85e-05	0.000529	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.81e-05	0.000525	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MAPK3—kidney cancer	4.78e-05	0.000521	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MAPK3—kidney cancer	4.78e-05	0.000521	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.7e-05	0.000513	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SCARB1—kidney cancer	4.68e-05	0.00051	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SCARB1—kidney cancer	4.66e-05	0.000508	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS1—kidney cancer	4.63e-05	0.000505	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GLIPR1—kidney cancer	4.62e-05	0.000503	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPAT—kidney cancer	4.62e-05	0.000503	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS1—kidney cancer	4.62e-05	0.000503	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	4.6e-05	0.000501	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	4.58e-05	0.000499	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—AMER1—kidney cancer	4.56e-05	0.000498	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.56e-05	0.000497	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MAPK1—kidney cancer	4.55e-05	0.000496	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MAPK1—kidney cancer	4.55e-05	0.000496	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PSMD7—kidney cancer	4.54e-05	0.000495	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PSMD7—kidney cancer	4.53e-05	0.000494	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ITPR2—kidney cancer	4.52e-05	0.000492	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.51e-05	0.000492	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PDHB—kidney cancer	4.49e-05	0.00049	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL2—kidney cancer	4.48e-05	0.000488	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	4.37e-05	0.000476	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.33e-05	0.000472	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—BCHE—kidney cancer	4.31e-05	0.00047	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—kidney cancer	4.3e-05	0.000468	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—kidney cancer	4.3e-05	0.000468	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—BCHE—kidney cancer	4.29e-05	0.000468	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—FH—kidney cancer	4.29e-05	0.000468	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—APRT—kidney cancer	4.29e-05	0.000468	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SLC5A5—kidney cancer	4.25e-05	0.000464	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	4.25e-05	0.000463	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SLC5A5—kidney cancer	4.24e-05	0.000462	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CCBL1—kidney cancer	4.23e-05	0.000461	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.19e-05	0.000457	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—SLC2A1—kidney cancer	4.11e-05	0.000448	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNA1—kidney cancer	4.09e-05	0.000446	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—SLC2A1—kidney cancer	4.09e-05	0.000446	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HSPB1—kidney cancer	4.07e-05	0.000444	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EIF4EBP1—kidney cancer	4.07e-05	0.000444	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GPC3—kidney cancer	4.03e-05	0.00044	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.99e-05	0.000435	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.97e-05	0.000433	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN2B—kidney cancer	3.95e-05	0.000431	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CA2—kidney cancer	3.92e-05	0.000428	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALAD—kidney cancer	3.82e-05	0.000417	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GPC3—kidney cancer	3.82e-05	0.000417	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.82e-05	0.000417	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TSC1—kidney cancer	3.79e-05	0.000413	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PSMD7—kidney cancer	3.79e-05	0.000413	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ANXA1—kidney cancer	3.79e-05	0.000413	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ST3GAL2—kidney cancer	3.73e-05	0.000407	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.71e-05	0.000405	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FLT1—kidney cancer	3.67e-05	0.0004	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GLIPR1—kidney cancer	3.66e-05	0.0004	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPAT—kidney cancer	3.66e-05	0.0004	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ALDH1A1—kidney cancer	3.65e-05	0.000398	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.62e-05	0.000394	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.6e-05	0.000393	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.58e-05	0.00039	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ST3GAL2—kidney cancer	3.54e-05	0.000386	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.5e-05	0.000382	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A3—kidney cancer	3.5e-05	0.000381	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PGK1—kidney cancer	3.5e-05	0.000381	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.48e-05	0.000379	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.46e-05	0.000378	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—LDHB—kidney cancer	3.43e-05	0.000374	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTP1—kidney cancer	3.43e-05	0.000374	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.43e-05	0.000373	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTP1—kidney cancer	3.41e-05	0.000372	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—FH—kidney cancer	3.41e-05	0.000371	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—APRT—kidney cancer	3.41e-05	0.000371	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JUNB—kidney cancer	3.4e-05	0.00037	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PAK1—kidney cancer	3.4e-05	0.00037	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.4e-05	0.00037	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.36e-05	0.000366	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.33e-05	0.000363	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC5A3—kidney cancer	3.32e-05	0.000362	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PGK1—kidney cancer	3.32e-05	0.000362	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LDHB—kidney cancer	3.25e-05	0.000355	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SFRP2—kidney cancer	3.25e-05	0.000355	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ABCB1—kidney cancer	3.24e-05	0.000354	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ABCB1—kidney cancer	3.23e-05	0.000352	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GPC3—kidney cancer	3.2e-05	0.000349	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HIF1A—kidney cancer	3.16e-05	0.000344	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TSC2—kidney cancer	3.15e-05	0.000343	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTM1—kidney cancer	3.15e-05	0.000343	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTM1—kidney cancer	3.14e-05	0.000342	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CA2—kidney cancer	3.12e-05	0.00034	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.11e-05	0.000339	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALAD—kidney cancer	3.04e-05	0.000331	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TCEB1—kidney cancer	3.03e-05	0.000331	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TCEB2—kidney cancer	3.03e-05	0.000331	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CYP1A1—kidney cancer	2.99e-05	0.000326	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CYP1A1—kidney cancer	2.97e-05	0.000324	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CA9—kidney cancer	2.97e-05	0.000324	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.97e-05	0.000324	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.96e-05	0.000323	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.96e-05	0.000323	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.94e-05	0.000321	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.91e-05	0.000317	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.9e-05	0.000316	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.88e-05	0.000314	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.87e-05	0.000313	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KIT—kidney cancer	2.78e-05	0.000303	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—APC—kidney cancer	2.78e-05	0.000303	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF2—kidney cancer	2.78e-05	0.000303	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A3—kidney cancer	2.78e-05	0.000303	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PGK1—kidney cancer	2.78e-05	0.000303	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN2B—kidney cancer	2.77e-05	0.000302	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—LDHB—kidney cancer	2.72e-05	0.000297	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1R—kidney cancer	2.69e-05	0.000293	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—BRAF—kidney cancer	2.61e-05	0.000285	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.59e-05	0.000282	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CRABP1—kidney cancer	2.53e-05	0.000276	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RPL14—kidney cancer	2.46e-05	0.000269	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.45e-05	0.000267	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.45e-05	0.000267	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.44e-05	0.000266	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.38e-05	0.00026	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CA9—kidney cancer	2.36e-05	0.000257	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ITPR2—kidney cancer	2.35e-05	0.000256	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.33e-05	0.000254	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.31e-05	0.000252	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ITPR2—kidney cancer	2.23e-05	0.000243	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—POMC—kidney cancer	2.23e-05	0.000243	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—POMC—kidney cancer	2.22e-05	0.000242	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HIF1A—kidney cancer	2.21e-05	0.000241	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TSC2—kidney cancer	2.21e-05	0.00024	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.2e-05	0.00024	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RAF1—kidney cancer	2.18e-05	0.000238	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.17e-05	0.000236	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERBB2—kidney cancer	2.16e-05	0.000236	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ACHE—kidney cancer	2.14e-05	0.000234	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTT1—kidney cancer	2.14e-05	0.000234	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTOR—kidney cancer	2.13e-05	0.000232	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CD4—kidney cancer	2.13e-05	0.000232	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KDR—kidney cancer	2.11e-05	0.000231	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—kidney cancer	2.11e-05	0.00023	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.1e-05	0.000229	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SCARB1—kidney cancer	2.03e-05	0.000221	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.02e-05	0.00022	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CRABP1—kidney cancer	2.01e-05	0.000219	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1B—kidney cancer	2e-05	0.000218	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PSMD7—kidney cancer	1.97e-05	0.000215	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.96e-05	0.000213	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KIT—kidney cancer	1.95e-05	0.000212	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—APC—kidney cancer	1.95e-05	0.000212	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CTNNB1—kidney cancer	1.89e-05	0.000206	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—BCHE—kidney cancer	1.87e-05	0.000204	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PSMD7—kidney cancer	1.87e-05	0.000204	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ITPR2—kidney cancer	1.87e-05	0.000204	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—POMC—kidney cancer	1.85e-05	0.000202	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC5A5—kidney cancer	1.84e-05	0.000201	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—kidney cancer	1.84e-05	0.000201	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BRAF—kidney cancer	1.83e-05	0.0002	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC2A1—kidney cancer	1.78e-05	0.000194	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—kidney cancer	1.78e-05	0.000194	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—kidney cancer	1.77e-05	0.000193	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.73e-05	0.000188	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.72e-05	0.000188	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ACHE—kidney cancer	1.7e-05	0.000186	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTT1—kidney cancer	1.7e-05	0.000186	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC2A1—kidney cancer	1.69e-05	0.000184	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JUNB—kidney cancer	1.68e-05	0.000183	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SCARB1—kidney cancer	1.61e-05	0.000176	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTGS1—kidney cancer	1.59e-05	0.000174	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MAPK3—kidney cancer	1.57e-05	0.000172	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PSMD7—kidney cancer	1.56e-05	0.000171	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—kidney cancer	1.55e-05	0.000169	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—kidney cancer	1.54e-05	0.000168	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—kidney cancer	1.53e-05	0.000167	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RAF1—kidney cancer	1.53e-05	0.000167	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RELA—kidney cancer	1.52e-05	0.000166	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—kidney cancer	1.51e-05	0.000165	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.51e-05	0.000164	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MAPK1—kidney cancer	1.5e-05	0.000163	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MTOR—kidney cancer	1.49e-05	0.000163	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTP1—kidney cancer	1.49e-05	0.000162	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—BCHE—kidney cancer	1.48e-05	0.000162	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC5A5—kidney cancer	1.46e-05	0.00016	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC2A1—kidney cancer	1.41e-05	0.000154	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—kidney cancer	1.41e-05	0.000154	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ABCB1—kidney cancer	1.41e-05	0.000153	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1B—kidney cancer	1.4e-05	0.000153	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—kidney cancer	1.37e-05	0.000149	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—kidney cancer	1.37e-05	0.000149	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN2B—kidney cancer	1.36e-05	0.000149	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—kidney cancer	1.34e-05	0.000146	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JUN—kidney cancer	1.33e-05	0.000145	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CTNNB1—kidney cancer	1.32e-05	0.000144	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PIK3CA—kidney cancer	1.3e-05	0.000142	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP1A1—kidney cancer	1.29e-05	0.000141	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—kidney cancer	1.29e-05	0.000141	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.2e-05	0.00013	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTP1—kidney cancer	1.18e-05	0.000129	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—VEGFA—kidney cancer	1.17e-05	0.000127	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ABCB1—kidney cancer	1.12e-05	0.000122	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK3—kidney cancer	1.1e-05	0.00012	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PIK3CA—kidney cancer	1.09e-05	0.000119	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HIF1A—kidney cancer	1.09e-05	0.000119	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TSC2—kidney cancer	1.09e-05	0.000119	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PIK3CA—kidney cancer	1.09e-05	0.000119	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—kidney cancer	1.08e-05	0.000118	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—kidney cancer	1.07e-05	0.000117	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.06e-05	0.000116	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MAPK1—kidney cancer	1.05e-05	0.000114	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP1A1—kidney cancer	1.03e-05	0.000112	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—kidney cancer	9.9e-06	0.000108	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—POMC—kidney cancer	9.65e-06	0.000105	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KIT—kidney cancer	9.61e-06	0.000105	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—APC—kidney cancer	9.61e-06	0.000105	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PIK3CA—kidney cancer	9.1e-06	9.92e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BRAF—kidney cancer	9.04e-06	9.85e-05	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—kidney cancer	8.8e-06	9.6e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.44e-06	9.21e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—kidney cancer	7.7e-06	8.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—POMC—kidney cancer	7.66e-06	8.35e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RAF1—kidney cancer	7.54e-06	8.23e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—kidney cancer	7.46e-06	8.14e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTOR—kidney cancer	7.37e-06	8.03e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CD4—kidney cancer	7.35e-06	8.02e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1B—kidney cancer	6.91e-06	7.54e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—kidney cancer	6.71e-06	7.32e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CTNNB1—kidney cancer	6.53e-06	7.12e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—kidney cancer	6.36e-06	6.94e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAPK3—kidney cancer	5.44e-06	5.93e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—kidney cancer	5.33e-06	5.81e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—kidney cancer	5.29e-06	5.77e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MAPK1—kidney cancer	5.17e-06	5.64e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—kidney cancer	4.89e-06	5.33e-05	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PIK3CA—kidney cancer	4.74e-06	5.16e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PIK3CA—kidney cancer	4.49e-06	4.9e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PIK3CA—kidney cancer	3.76e-06	4.1e-05	CbGpPWpGaD
